Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement.

@article{Marcassa2008ClinicalVC,
  title={Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement.},
  author={Claudio Marcassa and Jeroen J. Bax and Frank M. Bengel and Birger Hesse and Claus Leth Petersen and E Castro Reyes and Richard Underwood},
  journal={European heart journal},
  year={2008},
  volume={29 4},
  pages={557-63}
}
Mortality rates due to coronary artery disease (CAD) have declined in recent years as result of improved prevention, diagnosis, and management. Nonetheless, CAD remains the leading cause of death worldwide with most casualties expected to occur in developing nations. Myocardial perfusion scintigraphy (MPS) provides a highly cost-effective tool for the early detection of obstructive CAD in symptomatic individuals and contributes substantially to stratification of patients according to their risk… CONTINUE READING
46 Citations
57 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 46 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 57 references

Similar Papers

Loading similar papers…